Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» RAS pathway
RAS pathway
Oncology biotech Revolution Medicines sets terms for $150 million IPO
NASDAQ
Mon, 02/3/20 - 10:27 am
Revolution Medicines
IPOs
oncology
RAS pathway